Stock data
Puma Biotechnology Inc (PBYI)
Puma Biotechnology Inc (PBYI) reported revenue of US$228.37M and net income of US$31.11M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$228.37M | — | US$37.30M | US$31.11M | — |
| 2024 | US$230.47M | — | US$30.97M | US$30.28M | — |
| 2023 | US$235.64M | — | US$32.64M | US$21.59M | — |
| 2022 | US$228.03M | — | US$23.72M | US$0.00M | — |
| 2021 | US$253.16M | — | US$1.29M | -US$29.13M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$56.50M | US$8.19M | — |
| 2026-03-31 | US$44.81M | -US$3.75M | — |
| 2025-12-31 | US$75.45M | US$13.44M | — |
| 2025-09-30 | US$54.48M | US$8.84M | — |
| 2025-06-30 | US$52.44M | US$5.86M | — |
| 2025-03-31 | US$46.01M | US$2.97M | — |
| 2024-12-31 | US$59.08M | US$19.30M | — |
| 2024-09-30 | US$80.54M | US$20.32M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.